Astrana Health Inc. (ASTH)

In the past six months, Astrana Health's stock price has experienced a significant decline. Between December 26, 2024, and December 24, 2025, the share price decreased by 25.08%. More broadly, the stock price dropped 39.1% to $25.63 per share since November 2024. Key events impacting the stock include the Q3 2025 Earnings Report, where Astrana Health reported total revenue of $956.0 million, a 100% increase year-over-year, but missed diluted earnings per share estimates and lowered its full-year revenue and Adjusted EBITDA guidance. The Prospect Health acquisition closed on July 2, 2025, involving approximately 600,000 members in value-based arrangements, primarily in Southern California, with guided synergies of $12 million to $15 million expected within the first 12 to 18 months.

Information regarding the specific demand seasonality for Astrana Health's products and services is not explicitly detailed. Analysis of ASTH's stock performance seasonality indicates a historical "Buy Date" of November 30 and a "Sell Date" of February 27, which has resulted in a geometric average return of 7.38% above the S&P 500 Total Return Index over the past 18 years. This seasonal timeframe for the stock correlates poorly with the broader Healthcare sector's period of seasonal strength, suggesting that while there are seasonal patterns in the stock's performance, they do not directly align with the general seasonal trends of the healthcare sector.

Astrana Health, Inc. is a physician-centric, technology-powered, and risk-bearing healthcare management company operating in the Healthcare sector. Its core business revolves around an integrated healthcare delivery platform that empowers providers to participate in value-based care arrangements, aiming to deliver high-quality and cost-effective care to patients. Astrana Health provides medical care services through three main segments: Care Partners, Care Delivery, and Care Enablement. Its major products and services include Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory services. The company also offers comprehensive care coordination services to various stakeholders in the healthcare system and focuses on managing the health of populations through innovative care models and integrated health solutions, partnering with health plans, employers, and providers.

Astrana Health's geographic footprint has expanded across the United States, originating from East Los Angeles. The company strategically places its care delivery sites within the regions it serves, complementing its affiliate provider network. Astrana Health entered Arizona through its Care Partners segment, establishing a partnership with a large primary care physician group that serves over 50,000 patients across Medicare, Medicaid, and commercial lines of business.

Astrana Health's brand reputation is subject to ongoing regulatory challenges and competitive pressures within the fragmented healthcare industry. Competition comes from larger entities with greater financial and personnel resources, such as Regal Medical Group, Lakeside Medical Group, and Optum, which could potentially impact Astrana Health's market share and growth. Additionally, cybersecurity risks and potential data breaches remain a significant threat that could compromise patient trust and lead to financial and reputational damage. While no specific major reputation-damaging events were detailed in the past year, these inherent industry challenges consistently influence brand perception.

Astrana Health, Inc. has a diverse ownership structure, with significant holdings by institutional investors and company insiders. Approximately 47.51% to 48.32% of the company's stock is held by institutional shareholders, including major holders like BlackRock, Inc., Vanguard Group Inc, iShares Core S&P Small-Cap ETF (IJR), State Street Corp, and Dimensional Fund Advisors Lp. Insiders hold a substantial portion of the company's stock, with figures ranging from 47.30% to 241.31%. Kenneth T. Sim is the largest individual shareholder, owning 33.96 million shares, representing 60.32% of the company. Other significant insider owners include Thomas S. Lam and Albert Waichow Young.